Correlation Between Spyre Therapeutics and Capital Clean

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Capital Clean at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Capital Clean into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Capital Clean Energy, you can compare the effects of market volatilities on Spyre Therapeutics and Capital Clean and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Capital Clean. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Capital Clean.

Diversification Opportunities for Spyre Therapeutics and Capital Clean

0.42

Correlation Coefficient

Spyre Therapeutics  Capital Clean

Very weak diversification

The 3 months correlation between Spyre and Capital is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Capital Clean Energy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Capital Clean Energy and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Capital Clean. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Capital Clean Energy has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Capital Clean go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Capital Clean

Given the investment horizon of 90 days Spyre Therapeutics is expected to under-perform the Capital Clean. In addition to that, Spyre Therapeutics is 2.54 times more volatile than Capital Clean Energy. It trades about -0.17 of its total potential returns per unit of risk. Capital Clean Energy is currently generating about -0.02 per unit of volatility. If you would invest  1,862  in Capital Clean Energy on October 26, 2024 and sell it today you would lose (48.00) from holding Capital Clean Energy or give up 2.58% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Spyre Therapeutics  vs.  Capital Clean Energy

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Capital Clean Energy

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Capital Clean Energy has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Capital Clean is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Spyre Therapeutics and Capital Clean

The main advantage of trading using opposite Spyre Therapeutics and Capital Clean positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Capital Clean can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Capital Clean will offset losses from the drop in Capital Clean's long position.

The idea behind Spyre Therapeutics and Capital Clean Energy pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.